Daiwa Securities Group
NKTR icon

Daiwa Securities Group’s Nektar Therapeutics NKTR Stock Holding History

Daiwa Securities Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36
Closed – – 1367
2023
Q3 		$0 Hold
36
– – ﹤0.01% 1322
2023
Q2 		$0 Hold
36
– – ﹤0.01% 1338
2023
Q1 		$0 Hold
36
– – ﹤0.01% 1313
2022
Q4 		$1K Hold
36
– – ﹤0.01% 1281
2022
Q3 		$2K Hold
36
– – ﹤0.01% 1239
2022
Q2 		$2K Hold
36
– – ﹤0.01% 1246
2022
Q1 		$3K Hold
36
– – ﹤0.01% 1222
2021
Q4 		$7K Sell
36
-6
-14% -$1.3K ﹤0.01% 1172
2021
Q3 		$11K Buy
42
+18
+75% +$4.33K ﹤0.01% 1129
2021
Q2 		$6K Hold
24
– – ﹤0.01% 1064
2021
Q1 		$7K Buy
24
+2
+9% +$622 ﹤0.01% 1059
2020
Q4 		$6K Sell
22
-44
-67% -$11.4K ﹤0.01% 1048
2020
Q3 		$16K Hold
66
– – ﹤0.01% 1010
2020
Q2 		$18K Hold
66
– – ﹤0.01% 1029
2020
Q1 		$18K Hold
66
– – ﹤0.01% 1015
2019
Q4 		$21K Sell
66
-455
-87% -$132K ﹤0.01% 1011
2019
Q3 		$142K Buy
521
+36
+7% +$13.2K ﹤0.01% 909
2019
Q2 		$259K Sell
485
-1
-0.2% -$501 ﹤0.01% 829
2019
Q1 		$245K Hold
486
– – ﹤0.01% 827
2018
Q4 		$240K Buy
486
+16
+3% +$9.66K ﹤0.01% 789
2018
Q3 		$429K Buy
470
+34
+8% +$29K ﹤0.01% 695
2018
Q2 		$320K Buy
436
+366
+523% +$422K ﹤0.01% 775
2018
Q1 		$111K Buy
+70
New +$90.2K ﹤0.01% 901

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Daiwa Securities Group's NKTR Position: Q4 2023 in Review

Daiwa Securities Group sold out of Nektar Therapeutics (NKTR) in Q4 2023, closing a stake of 36 shares.

Daiwa Securities Group first reported a position in NKTR in Q1 2018 and held it in 23 quarters. The position peaked at $429K in Q3 2018. 125 funds tracked by Wall St. Rank hold NKTR as of Q4 2023.

  • Daiwa Securities Group reported no remaining Nektar Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 36 Nektar Therapeutics shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Nektar Therapeutics in Q1 2018 and held it in 23 quarters.
  • Daiwa Securities Group's Nektar Therapeutics position peaked at $429K in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.